Oncternal Therapeutics, Inc. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Oncternal Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Oncternal Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -136 %, a 79.9% decline year-over-year.
  • Oncternal Therapeutics, Inc. annual Return On Equity for 2023 was -95.9 %, a 53.9% decline from 2022.
  • Oncternal Therapeutics, Inc. annual Return On Equity for 2022 was -62.3 %, a 95.5% decline from 2021.
  • Oncternal Therapeutics, Inc. annual Return On Equity for 2021 was -31.9 %, a 31.3% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -136 -60.4 -79.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -108 -36.2 -50.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -95.9 -33.6 -53.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -85.3 -32.7 -62.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -75.7 -28.9 -61.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -71.5 -32.9 -85% Jan 1, 2023 Mar 31, 2023
Q4 2022 -62.3 -30.4 -95.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -52.6 -27.9 -113% Jul 1, 2022 Sep 30, 2022
Q2 2022 -46.7 -22.5 -92.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -38.6 -8.73 -29.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -31.9 +14.5 +31.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -24.7 +126 +83.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -24.3 +123 +83.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -29.9 +193 +86.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -46.4 +535 +92% Oct 1, 2020 Dec 31, 2020
Q3 2020 -151 -845 -122% Jul 1, 2020 Sep 30, 2020
Q2 2020 -147 -340 -177% Apr 1, 2020 Jun 30, 2020
Q1 2020 -223 -264 -645% Jan 1, 2020 Mar 31, 2020
Q4 2019 -581 -622 -1531% Oct 1, 2019 Dec 31, 2019
Q3 2019 694 +636 +1098% Jul 1, 2019 Sep 30, 2019
Q2 2019 192 -112 -36.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 40.9 +1.5K Jan 1, 2019 Mar 31, 2019
Q4 2018 40.6 +306 Oct 1, 2018 Dec 31, 2018
Q3 2018 58 +184 Jul 1, 2018 Sep 30, 2018
Q2 2018 304 +496 Apr 1, 2018 Jun 30, 2018
Q1 2018 -1.46K -1.3K -807% Jan 1, 2018 Mar 31, 2018
Q4 2017 -265 -170 -178% Oct 1, 2017 Dec 31, 2017
Q3 2017 -126 -25.8 -25.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 -192 -422 -184% Apr 1, 2017 Jun 30, 2017
Q1 2017 -161 -4.08K -104% Jan 1, 2017 Mar 31, 2017
Q4 2016 -95.3 -905 -112% Oct 1, 2016 Dec 31, 2016
Q3 2016 -100 +1.68K +94.4% Jul 1, 2016 Sep 30, 2016
Q2 2016 229 +2.37K Apr 1, 2016 Jun 30, 2016
Q1 2016 3.92K +4.14K Jan 1, 2016 Mar 31, 2016
Q4 2015 809 +1.04K Oct 1, 2015 Dec 31, 2015
Q3 2015 -1.78K -1.57K -742% Jul 1, 2015 Sep 30, 2015
Q2 2015 -2.14K -1.93K -894% Apr 1, 2015 Jun 30, 2015
Q1 2015 -220 -21.2 -10.7% Jan 1, 2015 Mar 31, 2015
Q4 2014 -229 -38.6 -20.3% Oct 1, 2014 Dec 31, 2014
Q3 2014 -212 -68.2 -47.5% Jul 1, 2014 Sep 30, 2014
Q2 2014 -216 -142 -193% Apr 1, 2014 Jun 30, 2014
Q1 2014 -199 -140 -240% Jan 1, 2014 Mar 31, 2014
Q4 2013 -190 -141 -289% Oct 1, 2013 Dec 31, 2013
Q3 2013 -144 -99.5 -226% Jul 1, 2013 Sep 30, 2013
Q2 2013 -73.6 -11.4 -18.4% Apr 1, 2013 Jun 30, 2013
Q1 2013 -58.5 -3.69 -6.73% Jan 1, 2013 Mar 31, 2013
Q4 2012 -49 Oct 1, 2012 Dec 31, 2012
Q3 2012 -44.1 Jul 1, 2012 Sep 30, 2012
Q2 2012 -62.2 Apr 1, 2012 Jun 30, 2012
Q1 2012 -54.8 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.